Overview

Safety and Efficacy Studies of rHSA/GCSF Fusion Protein For Injection to Treat Neutropenia

Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
Safety and efficacy studies of rHSA/GCSF fusion protein for injection in treatment of neutropenia induced by chemotherapy of cancer patients.
Phase:
Phase 1
Details
Lead Sponsor:
Tianjin SinoBiotech Ltd.
Collaborator:
Beijing Cancer Hospital